Vaxcell Bio
2 known investors
Find your way into Vaxcell Bio
VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.
Investors · 2
Frequently asked questions
- What does Vaxcell Bio do?
- VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.
- Who are Vaxcell Bio's investors?
- Vaxcell Bio's investors include Aju IB Invesment Corporation, LB Investment.